The IMNOVYD brand, founded in 2010 (United States), from
126 sister brands
and 17477 competing brands.
The IMNOVYD brand is owned by Celgene, a company listed in New York.
IMNOVYD is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.